The European Union’s medicines authority says it has begun evaluating a new drug for treating COVID-19 patients who do not require extra oxygen but are at increased risk of developing severe symptoms of the disease
Related posts
-
Buffalo Grove DePaul student speaks out about antisemitic campus attack
A Stevenson High School graduate and DePaul University student spoke out about a campus antisemitic attack. -
Bill to phase out subminimum wage for disabled workers clears General Assembly
A long-awaited bill to stop Illinois organizations from paying subminimum wage to workers with disabilities will... -
Apartment developer launches Yorktown mall project; first phase calls for 271 units
Going into the busy holiday shopping season, visitors to Yorktown Center are seeing visible progress on...